Skip to main content
. 2016 Jan 2;6:476–481. doi: 10.1016/j.dib.2015.12.030

Table 2.

Comparison of baseline variables between those with DCE-MRI measurements and those with DCE-MRI but who were excluded due to image quality, protocol violations or wall thickness<1 mm.

Variable DCE-MRI subjectsa
P-value
Included (N=98) Excluded (N=108)
Sex – no. (%) 0.46
 Male 84 (86%) 88 (81%)
 Female 14 (14%) 20 (19%)
Age – years 62±9 61±8 0.30
Raceb – no. (%) 0.026
 White 90 (92%) 86 (80%)
 Non-white/other 8 (8%) 21 (20%)
Ethnicityb – no. (%) 0.38
 Hispanic or Latino 4 (4%) 8 (7%)
 Not Hispanic or Latino 93 (96%) 100 (93%)
Tobacco use – no. (%) 0.48
 Current 21 (21%) 17 (16%)
 Former (quit>1 year ago) 48 (49%) 61 (56%)
 Never used 29 (30%) 30 (28%)
Duration of statin therapy – no. (%) 0.76
 <1 year 21 (21%) 28 (26%)
 1–5 years 39 (40%) 40 (37%)
 >5 years 38 (39%) 40 (37%)
Prior use of niacin – no. (%) 15 (15%) 22 (20%) 0.37
Presence of metabolic syndrome – no. (%) 79 (81%) 87 (81%) >0.99
History of diabetes – no. (%) 22 (22%) 32 (30%) 0.27
Body mass indexb – kg / m2 29.7±4.1 30.9±4.8 0.064
Systolic blood pressureb – mmHg 129±18 128±17 0.87
Diastolic blood pressureb – mmHg 75±10 75±9 0.72
Total cholesterol – mg/dl 139±23 141±28 0.92
LDL cholesterol – mg/dl 71±18 73±25 0.91
Non-HDL cholesterol – mg/dl 105±21 107±28 0.88
Triglycerides – mg/dl 169±62 171±63 0.78
Lipoprotein(a)b – mg/dl 83.6±89.8 73.5±92.0 0.41
ApoBb – mg/dl 82.2±19.0 82.5±21.4 0.97
HDL cholesterol – mg/dl 34.3±6.1 34.9±5.2 0.62
ApoA-Ib – mg/dl 118.9±16.4 123.9±16.7 0.10
Total:HDL ratio 4.2±0.8 4.1±1.1 0.67
ApoB:ApoA-I ratiob 0.7±0.2 0.7±0.2 0.29

Unless otherwise specified, values are no. (%) or means±SD.

a

Only includes those already on statins at enrollment with known prior duration.

b

Individuals missing values excluded for comparisons involving that variable, including: race (n=1), ethnicity (n=1), body mass index (n=1), systolic blood pressure (n=1), diastolic blood pressure (n=1), lipoprotein(a) (n=2), apoB (n=2), apoA-I (n=2) and apoB: apoA-I ratio (n=2).